OMERS ADMINISTRATION Corp Purchases 32,800 Shares of Bruker Co. (NASDAQ:BRKR)

OMERS ADMINISTRATION Corp boosted its position in shares of Bruker Co. (NASDAQ:BRKR - Free Report) by 21.7% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 184,200 shares of the medical research company's stock after buying an additional 32,800 shares during the period. OMERS ADMINISTRATION Corp owned approximately 0.12% of Bruker worth $10,798,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of the company. Sterling Capital Management LLC raised its stake in Bruker by 29.0% during the fourth quarter. Sterling Capital Management LLC now owns 3,514 shares of the medical research company's stock worth $206,000 after acquiring an additional 791 shares in the last quarter. Merit Financial Group LLC bought a new position in shares of Bruker in the 4th quarter valued at $300,000. Bank of New York Mellon Corp boosted its holdings in shares of Bruker by 7.6% during the 4th quarter. Bank of New York Mellon Corp now owns 988,863 shares of the medical research company's stock valued at $57,967,000 after acquiring an additional 69,806 shares in the last quarter. Blue Trust Inc. raised its holdings in Bruker by 13.5% in the 4th quarter. Blue Trust Inc. now owns 2,164 shares of the medical research company's stock valued at $127,000 after buying an additional 257 shares during the last quarter. Finally, Wells Fargo & Company MN increased its position in Bruker by 95.1% during the 4th quarter. Wells Fargo & Company MN now owns 190,855 shares of the medical research company's stock valued at $11,188,000 after purchasing an additional 93,048 shares during the period. 79.52% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of analysts have weighed in on the company. Citigroup decreased their price target on Bruker from $75.00 to $50.00 and set a "buy" rating for the company in a report on Monday, April 7th. Stifel Nicolaus reduced their price target on shares of Bruker from $57.00 to $48.00 and set a "hold" rating for the company in a report on Thursday, May 8th. Wells Fargo & Company dropped their price objective on shares of Bruker from $75.00 to $60.00 and set an "overweight" rating on the stock in a report on Thursday, April 17th. The Goldman Sachs Group decreased their price objective on Bruker from $50.00 to $45.00 and set a "neutral" rating for the company in a report on Thursday, May 8th. Finally, Guggenheim reaffirmed a "buy" rating on shares of Bruker in a research report on Monday, February 24th. Six equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to MarketBeat, Bruker presently has a consensus rating of "Moderate Buy" and a consensus price target of $60.10.

Bruker Stock Up 2.3%

Shares of NASDAQ BRKR traded up $0.84 during trading on Friday, hitting $37.53. The stock had a trading volume of 1,786,228 shares, compared to its average volume of 1,606,070. The company has a debt-to-equity ratio of 1.15, a current ratio of 1.60 and a quick ratio of 0.77. The company has a market capitalization of $5.69 billion, a PE ratio of 49.38, a PEG ratio of 2.16 and a beta of 1.23. The firm has a fifty day moving average of $40.49 and a two-hundred day moving average of $50.65. Bruker Co. has a 12 month low of $34.10 and a 12 month high of $79.78.

Bruker (NASDAQ:BRKR - Get Free Report) last issued its earnings results on Wednesday, May 7th. The medical research company reported $0.47 EPS for the quarter, topping the consensus estimate of $0.46 by $0.01. The business had revenue of $801.40 million during the quarter, compared to the consensus estimate of $763.83 million. Bruker had a return on equity of 21.01% and a net margin of 3.36%. The firm's revenue was up 11.0% compared to the same quarter last year. During the same quarter last year, the company earned $0.53 EPS. As a group, equities research analysts forecast that Bruker Co. will post 2.69 EPS for the current fiscal year.

Bruker Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 27th. Shareholders of record on Monday, June 16th will be given a dividend of $0.05 per share. The ex-dividend date of this dividend is Monday, June 16th. This represents a $0.20 annualized dividend and a yield of 0.53%. Bruker's payout ratio is 38.46%.

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.